Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status

Fig. 5

Comparison of DSS curves in resected patients based on the preoperative CEA and pT stage. (a) There was significant difference of 5-year DSS between resected patients with preoperative low CEA levels (< 8.5 ng/mL) and high CEA levels (8.5 ng/mL and more) (p < 0.001). Seven patients with preoperative high CEA levels were classified as R (n = 4) and BR (n = 3). (b) There was significant difference of 5-year DSS between patients with pT1–3 and pT4 (p = 0.001). The resected patients with preoperative high CEA levels (more than 8.5 ng/ml) and / or pT4 were no significant differences of DSS compared to unresected patients. DSS: disease-specific survival, R: resectable, BR: borderline resectable, LA: locally advanced, CEA: carcinoembryonic antigen, MST: median survival time

Back to article page